The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index; 7 of the 28 sources its claims cite were checked for support.
Abstract
Global prospects for COVID-19 control: Lower-income countries have recognized the potential impact of coronavirus disease 2019 (COVID-19) from observing ongoing epidemics. Many have intervened quickly and early with measures to slow viral transmission, which may partly explain the low rates observed so far in these countries. Walker et al. calibrated a global model with country-specific data (see the Perspective by Metcalf et al. ). Despite the potentially protective effects of younger demographics, the closer intergenerational contact, limitations on health care facilities, and frequency of comorbidities in lower-income countries require sustained nonpharmaceutical interventions (NPIs) to avoid overwhelming health care capacity. As a result of strict NPIs, the protective effects of immunity will be reduced, and it will be important to improve testing capacity. Ensuring equitable provision of oxygen and—when they are ready—pharmaceutical interventions should be a global priority. Science , this issue p. 413 ; see also p. 368
Overview
CoChat Summary
TL;DR
Walker et al. model COVID-19 in low- and middle-income countries using demographic, contact, and health-system data, finding that younger populations reduce per-capita risk but limited health care capacity and quality can offset this advantage. They conclude sustained nonpharmaceutical interventions, especially suppression, are needed to avoid overwhelming health systems, with major testing and oxygen gaps.
Key findings
- In an unmitigated epidemic with R0 = 3.0, attack rates are similar across settings, slightly higher in LICs due to more homogeneous age mixing; assuming the same comorbidity profile and China-level care, lower-income settings have lower per-capita hospitalization, critical care, and mortality because of younger demography.
- Health care capacity is strongly income-graded: LICs have a median 1.28 hospital beds per 1000 population versus 4.68 in HICs; ICU beds are 1.47% of hospital beds in LICs versus 3.30% in HICs. Under mitigation, peak critical care demand exceeds supply by a factor of 30.7 (95% UI 14.7–48.8) in a typical LIC versus 7.8 (95% UI 3.6–13.0) in a typical HIC; LMICs and UMICs show factors of 17.5 and 10.9, respectively.
- Under mitigation, modeled deaths per 1000 population in LICs are 2.1 (95% UI 1.0–3.3) with unlimited HIC-quality care, 4.6 (95% UI 1.4–10.0) with capacity limits, and 6.5 (95% UI 2.7–12.3) with poorer-quality care; in LMICs the corresponding estimates are 2.4 (1.1–3.9), 3.9 (1.5–8.9), and 6.2 (2.8–11.9). Excess deaths due to poorer quality and lack of capacity are 4.4 (1.7–9.0) and 3.8 (1.7–8.0) per 1000 in LICs and LMICs, respectively.
- For R0 = 3.0, optimal mitigation reduces infections by 30–38% (median 33%) and mortality by 19–55% (median 39%); adding enhanced social distancing of elderly individuals raises mortality reduction to 23–67% (median 49%). Proportional mortality reductions are lower in LICs (median 25.3% vs 49.9% in HICs for optimized mitigation including social distancing; 32.6% vs 60.1% with elderly-enhanced distancing). Suppression with a 75% contact reduction gives Rt = 0.75 for R0 = 3.0; to keep ICU demand below capacity, LICs are predicted to spend 77% of an 18-month period in suppression versus 66% in HICs. Prior to suppression, median reported cases per death were 8.6 in LICs, 19.3 in LMICs, and 72.6 in HICs.
Methods
- Collated global demographic projections by age and country and social mixing data by age and country-level income; used a simple SIR model to estimate final attack rates and applied age-specific hospitalization, critical care, and infection fatality ratio estimates, with central R0 = 3.0 (range 2.3–3.5).
- Modeled health care supply using a boosted regression tree with World Bank covariates to predict hospital beds per 1000 population, combined with ICU beds per 100 hospital beds from a systematic review; integrated expert clinical opinion on COVID-19 outcomes under scenarios of unlimited, limited, and limited/no mechanical ventilation/poorer-quality care.
- Used an age-structured SEIR model to explore mitigation (Rt > 1) and suppression (Rt < 1) under health-system capacity constraints, generating 500 parameter sets with 10 stochastic realizations each; reviewed the ACAP COVID-19 Government Response Measures dataset to summarize when countries implemented suppression measures.
Limitations
- Stated: the paper cannot predict exact cases, mortality, or disease burden for any country, and full understanding will only be available retrospectively; it does not quantify wider societal and economic impacts, nor does it address the challenge of intensive suppression in LICs/LMICs where informal labor limits adherence.
- Stated: durable immunity to reinfection remains uncertain; all symptomatic cases are assumed to seek care; hospital stay durations are based on UK data and likely shorter in LIC/LMIC settings, making results conservative; HIC ICU capacity estimates are drawn almost exclusively from a review of Asian countries and may not reflect HICs worldwide; health care quality estimates rely on expert clinical opinion with likely heterogeneity not captured.
- Evident: the model does not specify the combinations of NPIs needed to achieve contact reductions, and it does not include pharmaceutical interventions except through an assumed 18-month time window; income-stratified representative settings and contact surveys may not capture within-country heterogeneity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
4 Valid · 1 Not valid · 16 Not checked · 64 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, this single peak relies upon the assumption that recovery from infection confers durable immunity to reinfection, which has yet to be conclusively demonstrated (16).”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Mitigation and suppression strategies for low- and middle-income countries
What the sources say
- Supportedcites [16] Altmann D. M., Douek D. C., Boyton R. J., What policy makers need to know about COVID-19 protective immunity. Lancet 395, 1527– 1529 (2020). 10.1016/S0140-6736(20)30985-5 32353328 PMC7185915 source
Our copy of Altmann et al. states directly that protection after recovery is unresolved: reinfection reports from China and South Korea are 'anecdotal' and 'should be regarded with caution' because PCR-negative 'recovered' individuals might have harboured persistent virus, with virus sequencing still needed to resolve the issue (reinfection passage). It also says 'There is no certainty as to the immunological correlates of antiviral protection or the proportion of the population who must attain them, making it impossible to identify a point when this level of immunity has been reached' (lockdown-exit passage), and on duration that the best estimate from related coronaviruses is that immunity 'might wane', with studies of just over 1 year 'of little reassurance' given possible waves in 3–4 years ('How long is immunity to COVID-19 likely to last?'). The 'single peak under optimal mitigation' framing is the citing paper's own model and is not attributed to this source; the clause the citation supports — that durable immunity to reinfection after recovery has yet to be conclusively demonstrated — is stated in our copy. (LLM, conf=0.85)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The experience in countries to date has emphasized the intense pressure that a COVID-19 epidemic places on national health systems, with demand for intensive care beds and mechanical ventilators rapidly outstripping their availability, even in relatively highly resourced settings (2).”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Abstract
What the sources say
- Partly supportedcites [2] Remuzzi A., Remuzzi G., COVID-19 and Italy: What next? Lancet 395, 1225– 1228 (2020). 10.1016/S0140-6736(20)30627-9 32178769 PMC7102589 sourceExperimental — accuracy not yet measured
The Modelling predictions section forecasts that Italy’s intensive-care capacity would be reached within days, and the Conclusion describes enormous pressure in Lombardy and an urgent plan to provide 5,000 more ventilators. The paper supports the pressure on a relatively well-resourced health system, but it presents demand exceeding capacity chiefly as a prediction, not an established outcome across countries; it also does not establish that ventilator demand had already outstripped availability. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, as has been observed, HICs and UMICs are likely to be able to put in place surge capacity to limit any impact on mortality (19–21).”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Mitigation and suppression strategies for low- and middle-income countries
What the sources say
- Partly supportedcites [19] Carenzo L., Costantini E., Greco M., Barra F. L., Rendiniello V., Mainetti M., Bui R., Zanella A., Grasselli G., Lagioia M., Protti A., Cecconi M., Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia 75, 928– 934 (2020). 10.1111/anae.15072 32246838 sourceExperimental — accuracy not yet measured
The Critical care area operations section (page unavailable) describes a Milan hospital expanding its ICU and ward capacity during the outbreak. It does not assess whether HICs and UMICs generally can do so, or whether surge capacity limits mortality. (LLM, conf=0.86)
- Partly supportedcites [20] A. Zangrillo et al, Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency. Crit. Care Resusc. (2020); www.ncbi.nlm.nih.gov/pubmed/32227819. PMC10692483 32227819 sourceExperimental — accuracy not yet measured
The ‘Increasing intensive care unit and general ward capacity’ section (page not provided) documents a Milan hospital’s rapid expansion of ICU capacity to 72 beds. It does not assess whether HICs and UMICs generally can do so or whether surge capacity limits mortality. (LLM, conf=0.86)
- Not checked yetcites [21] Litton E., Bucci T., Chavan S., Ho Y. Y., Holley A., Howard G., Huckson S., Kwong P., Millar J., Nguyen N., Secombe P., Ziegenfuss M., Pilcher D., Surge capacity of intensive care units in case of acute increase in demand caused by COVID-19 in Australia. Med. J. Aust. 212, 463– 467 (2020). 10.5694/mja2.50596 32306408 PMC7264562 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Once the number of new infections drops to a manageable level, it is likely that more widespread testing and isolation of cases coupled with contact tracing can help to prevent a resurgence of transmission, as has been observed in countries such as South Korea (26–28).”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Suppression and longer-term exit strategies
What the sources say
- Not checked yetcites [26] Consulate General of the Republic of Korea, “Flattening the curve on COVID-19 - How Korea responded to a pandemic using ICT” (2020); http://overseas.mofa.go.kr/us-houston-en/brd/m_5573/view.do?seq=759765.
- Partly supportedcites [27] COVID-19 National Emergency Response Center, Epidemiology & Case Management Team, Korea Centers for Disease Control & Prevention, Contact Transmission of COVID-19 in South Korea: Novel Investigation Techniques for Tracing Contacts. Osong Public Health Res. Perspect. 11, 60–63 (2020). PMC7045882 32149043 sourceExperimental — accuracy not yet measured
The Introduction describes contact management as a strategy to minimize additional transmission, and the Results describe tracing contacts and using quarantine or isolation in South Korea (pages not provided). The paper does not address more widespread testing, a threshold at which new infections become manageable, or an observed prevention of resurgence; the Discussion says the effectiveness of its monitoring methods still needs evaluation. (LLM, conf=0.87)
- Could not verifycites [28] Ainslie K. E. C., Walters C. E., Fu H., Bhatia S., Wang H., Xi X., Baguelin M., Bhatt S., Boonyasiri A., Boyd O., Cattarino L., Ciavarella C., Cucunuba Z., Cuomo-Dannenburg G., Dighe A., Dorigatti I., van Elsland S. L., FitzJohn R., Gaythorpe K., Ghani A. C., Green W., Hamlet A., Hinsley W., Imai N., Jorgensen D., Knock E., Laydon D., Nedjati-Gilani G., Okell L. C., Siveroni I., Thompson H. A., Unwin H. J. T., Verity R., Vollmer M., Walker P. G. T., Wang Y., Watson O. J., Whittaker C., Winskill P., Donnelly C. A., Ferguson N. M., Riley S., Evidence of initial success for China exiting COVID-19 sourceExperimental — accuracy not yet measured
The Introduction and Discussion describe containment in China and the relationship between movement and transmission. The Methods mention testing to define reported cases, but no passage addresses whether testing, isolation and contact tracing prevent resurgence or reports that outcome in South Korea. Searches for South Korea and for testing, isolation and contact tracing found no supporting passage. (LLM, conf=0.74)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“suppression will always have the greatest impact on COVID-related morbidity and mortality”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Conclusions
What the sources say
- Not checked yetcites [31] A. B. Hogan, B. Jewell, E. Sherrard-Smith, J. Vesga, O. J. Watson, C. Whittaker, et al., Report 19: The Potential Impact of the COVID-19 Epidemic on HIV, TB and Malaria in Low-and Middle-Income Countries; 10.25561/78670. 10.25561/78670
- Could not verifycites [32] Korenromp E. L., Lives saved from malaria prevention in Africa—Evidence to sustain cost-effective gains. Malar. J. 11, 94 (2012). 10.1186/1475-2875-11-94 22455309 PMC3373378 sourceExperimental — accuracy not yet measured
Our copy of Korenromp (2012) is entirely about malaria-prevention impact estimates with the Lives Saved Tool (ITN/LLIN coverage, ACT case management, IRS) in sub-Saharan Africa; no passage addresses SARS-CoV-2/COVID-19 or a 'suppression' strategy's relative impact on morbidity and mortality. Searches for 'suppression ... greatest impact on morbidity and mortality' and for 'coronavirus / influenza / pandemic / transmission reduction' returned only the Discussion (pp. on mortality measurement, dynamic transmission modelling, and the 2000 counterfactual) and reference-list entries. Since the paper neither states nor contradicts the claim, the attribution cannot be checked against this source. (LLM, conf=0.78)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
47 more claims
Create a free account to see all 85 claims and to verify the 20 references still open.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 7
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This variation can be explained by a combination of factors including policies enacted by governments to encourage mask use and reduce social interaction,48, 49, 50 presence of escape variants, testing and contact tracing capacity,51, 52 previous exposure to other coronaviruses,53 baseline patterns of social interaction, and more.”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredIn the citing paper
“The effect of COVID-19 on healthcare infrastructure in LMICs, however, is arguably more extreme due to the health system capacity and deeper dependency on families for support of PwD (Walker et al., 2020).”
From Robotic Telemedicine for Mental Health: A Multimodal Approach to Improve Human-Robot Engagement (2021) · cites this paper as Walker et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Worldwide | 121 | 24/03 (08/03–19/04) | 6.01 (0–449.24) | 0 (0–10.447) | 50 | 45.8 (5.1–325.2) |”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Suppression and longer-term exit strategies
Reported 50 · recomputed 49
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Self-citationPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationLauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)
Hale, T., Angrist, N., Goldszmidt, R., Kira, B., Petherick, A., Phillips, T., Webster, S., Cameron-Blake, E., Hallas, L., Majumdar, S., et al. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01079-8 · Cited by 4,578
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Self-citationHow will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,281
Self-citation
Cited by
Items 201–300 of 991
High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
Zang, Y., Su, M., Wang, Q., Cheng, X., Zhang, W., Zhao, Y., Chen, T., Jiang, Y., Shen, Q., Du, J., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac016 · Cited by 34
Dambha‐Miller, H., Albasri, A., Hodgson, S., Wilcox, C. R., Khan, S., Islam, N., Little, P. S., & Griffin, S. J. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040644 · Cited by 31
Kanu, F. A., Smith, E. E., Offutt-Powell, T. N., Hong, R., Teams3, D. C. I. A. C. T., Dinh, T., & Pevzner, E. S. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6945e1 · Cited by 31
Jalloh, M. F., Nur, S. A., Nur, S. A., Winters, M., Bedson, J., Pedi, D., Prybylski, D., Namageyo-Funa, A., Hageman, K., Baker, B. J., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004450 · Cited by 36
Martei, Y. M., Rick, T. J., Fadelu, T. A., Ezzi, M. S., Hammad, N., Quadri, N. S., Rodrigues, B., Simonds, H. M., Grover, S., Incrocci, L., et al. (2021) · JCO Global Oncology · doi:10.1200/go.20.00569 · Cited by 32
Nurse-midwives reconfiguring care in the scope of labor and births in COVID-19 times
Dulfe, P. A. M., Alves, V. H., Pereira, A. V., Vieira, B. D. G., Rodrigues, D. P., Marchiori, G. R. S., & Branco, M. B. L. R. (2021) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2020-0863 · Cited by 32
Gori, L., Manfredi, P., Marsiglio, S., & Sodini, M. (2021) · Journal of Public Economic Theory · doi:10.1111/jpet.12549 · Cited by 32
What have we learned about socioeconomic inequalities in the spread of COVID-19? A systematic review
Benita, F., Rebollar-Ruelas, L., & Alfaro, É. D. G. (2022) · Sustainable Cities and Society · doi:10.1016/j.scs.2022.104158 · Cited by 40
Patient-centric research in the time of COVID-19: conducting ethical COVID-19 research in Africa
Nembaware, V., Munung, N. S., Matimba, A., & Tiffin, N. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003035 · Cited by 31
Inference of COVID-19 epidemiological distributions from Brazilian hospital data
Hawryluk, I., Mellan, T. A., Hoeltgebaum, H., Mishra, S., Schnekenberg, R. P., Whittaker, C., Zhu, H., Gandy, A., Donnelly, C. A., Flaxman, S. R., et al. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0596 · Cited by 30
Self-citationEbrahimzadeh, A., Mohseni, S., Narimani, B., Ebrahimzadeh, A., Kazemi, S., Keshavarz, F., Yaghoubi, M. J., & Milajerdi, A. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2012419 · Cited by 30
Subnational analysis of the COVID-19 epidemic in BrazilPreprint
Mellan, T. A., Hoeltgebaum, H., Mishra, S., Whittaker, C., Schnekenberg, R. P., Gandy, A., Unwin, H. J. T., Vollmer, M., Coupland, H., Hawryluk, I., et al. (2020) · medRxiv · doi:10.1101/2020.05.09.20096701 · Cited by 30
Self-citationHu, L., Sun, J., Wang, Y., Tan, D. J., Cao, Z., Gao, L., Guan, Y., Jia, X., & Mao, J. (2023) · Vaccines · doi:10.3390/vaccines11061045 · Cited by 36
Self-citationMobile Technology Solution for COVID-19: Surveillance and Prevention
Ahmad, S., Chitkara, P., Khan, F. N., Kishan, A., Alok, V., Ramlal, A., & Mehta, S. (2020) · Studies in computational intelligence · doi:10.1007/978-981-15-8534-0_5 · Cited by 41
Hasan, M. K., Jawad, M. T., Hasan, K. N. I., Partha, S. B., Masba, M. M. A., Saha, S., & Moni, M. A. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100709 · Cited by 34
Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization
Miura, F., Leung, K. Y., Klinkenberg, D., Ainslie, K. E. C., & Wallinga, J. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009697 · Cited by 30
Self-citationThindwa, D., Jambo, K., Ojal, J., MacPherson, P., Phiri, M. D., Pinsent, A., Khundi, M., Chiume, L., Gallagher, K. E., Heyderman, R. S., et al. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100590 · Cited by 31
COVID-19 mortality effects of underlying health conditions in India: a modelling study
Novosad, P. M., Jain, R., Campion, A., & Asher, S. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-043165 · Cited by 33
Rapid review of COVID-19 epidemic estimation studies for Iran
Pourmalek, F., Hemami, M. R., Janani, L., & Moradi‐Lakeh, M. (2021) · BMC Public Health · doi:10.1186/s12889-021-10183-3 · Cited by 33
Prophylaxis for COVID-19: a systematic review
Smit, M., Marinosci, A., Agoritsas, T., & Calmy, A. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.01.013 · Cited by 29
Relationship of Test Positivity Rates with COVID-19 Epidemic Dynamics
Furuse, Y., Ko, Y. K., Ninomiya, K., Suzuki, M., & Oshitani, H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094655 · Cited by 40
The Impact of the COVID-19 on the Construction Industry in Vietnam
Tâm, N. V., Nguyen, B. N., Toản, N. Q., Dinh, H. T., & Chu, A. T. (2021) · International Journal of Built Environment and Sustainability · doi:10.11113/ijbes.v8.n3.745 · Cited by 35
Age-targeted dose allocation can halve COVID-19 vaccine requirementsPreprint
Meehan, M. T., Cocks, D., Caldwell, J. M., Trauer, J. M., Adekunle, A. I., Ragonnet, R. R., & McBryde, E. S. (2020) · medRxiv · doi:10.1101/2020.10.08.20208108 · Cited by 28
Mahikul, W., Chotsiri, P., Ploddi, K., & Ngum, W. P. (2021) · Biology · doi:10.3390/biology10020080 · Cited by 33
Impact of individual behavioral changes on epidemic spreading in time-varying networks
Wang, B., Xie, Z., & Han, Y. (2021) · Physical review. E · doi:10.1103/physreve.104.044307 · Cited by 27
Velásquez, S. R., Jacques, L., Dalal, J., Sestito, P., Habibi, Z., Venkatasubramanian, A., Nguimbis, B., Mesa, S. B., Chimbetete, C., Keiser, O., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.07.060 · Cited by 27
Jung, A.-S., Haldane, V. E., Neill, R., Wu, S., Jamieson, M., Verma, M., Tan, M. M. J., Foo, C. D., Abdalla, S. M., Shrestha, P., et al. (2021) · BMJ · doi:10.1136/bmj-2021-068954 · Cited by 34
Knaul, F. M., Touchton, M. M., Arreola‐Ornelas, H., Calderon-Anyosa, R. J. C., Otero-Bahamón, S., Hummel, C., Perez‐Cruz, P. E., Porteny, T., Patino, F. G., Atun, R. A., et al. (2022) · Health Affairs · doi:10.1377/hlthaff.2021.00981 · Cited by 32
OECD, & World Health Organization (2020) · Health at a glance. Asia/Pacific · doi:10.1787/1ad1c42a-en · Cited by 27
Xue, S., Kaufman, M., Zhang, X., Xia, S., Niu, C., Zhou, R., & Xu, W. (2022) · Psychology Research and Behavior Management · doi:10.2147/prbm.s364356 · Cited by 35
Hogan, A. B., Wu, S. L., Toor, J., Mesa, D. O., Doohan, P., Watson, O. J., Winskill, P., Charles, G. D., Barnsley, G., Riley, E. M., et al. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004195 · Cited by 29
Self-citationDemombynes, G., de Walque, D., Gubbins, P., Urdinola, P., & Veillard, J. H. M. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061589 · Cited by 28
Chae, S. Y., Lee, K.-E., Lee, H. M., Jung, N., Le, Q. A., Mafwele, B. J., Lee, T. H., Kim, D. H., & Lee, J. W. (2020) · Frontiers in Physics · doi:10.3389/fphy.2020.00311 · Cited by 26
Knowing Versus Doing: Protective Health Behaviour Against COVID-19 in Aceh, Indonesia
Chavarría, E., Diba, F., Marcus, M. E., Marthoenis, M., Reuter, A., Rogge, L., & Vollmer, S. (2021) · The Journal of Development Studies · doi:10.1080/00220388.2021.1898594 · Cited by 36
Envisioning a resilient future for biodiversity conservation in the wake of the COVID‐19 pandemic
Thurstan, R. H., Hockings, K. J., Hedlund, J. S. U., Bersacola, E., Collins, C., Early, R., Ermiasi, Y., Fleischer‐Dogley, F., Gilkes, G., Harrison, M. E., et al. (2021) · People and Nature · doi:10.1002/pan3.10262 · Cited by 28
Kuleto, V., Ilić, M. P., Šević, N. P., Ranković, M., Stojaković, D., & Dobrilović, M. (2021) · Sustainability · doi:10.3390/su132312935 · Cited by 33
Real-Time Infectious Disease Modeling to Inform Emergency Public Health Decision Making
Bershteyn, A., Kim, H., & Braithwaite, R. S. (2022) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-052220-093319 · Cited by 30
Sinha, B., Dudeja, S., Mazumder, S., Kumar, T., Adhikary, P., Roy, N., Chandola, T. R., Mehta, R., Raina, N., & Bhandari, N. (2022) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2022.816969 · Cited by 34
Ejigu, B. A., Asfaw, M. D., Cavalerie, L., Abebaw, T., Nanyingi, M. O., & Baylis, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259874 · Cited by 30
The Younger Age Profile of COVID-19 Deaths in Developing Countries
Chauvin, J. P., Fowler, A., & Nicolás Herrera, L. (2020) · doi:10.18235/0002879 · Cited by 30
Analyzing the impact of COVID-19 on consumption behaviors through recession and recovery patterns
Chen, R., Li, T., & Li, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-51215-3 · Cited by 29
Impact of the 100 days mission for vaccines on COVID-19: a mathematical modelling study
Barnsley, G., Mesa, D. O., Hogan, A. B., Winskill, P., Torkelson, A. A., Walker, D. G., Ghani, A. C., & Watson, O. J. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00286-9 · Cited by 28
Self-citationEvolution of COVID-19 Pandemic in India
Asad, A., Srivastava, S., & Verma, M. K. (2020) · Transactions of Indian National Academy of Engineering · doi:10.1007/s41403-020-00166-y · Cited by 32
Sosa-Rubí, S. G., Seiglie, J. A., Chivardi, C., Manne‐Goehler, J., Meigs, J. B., Wexler, D. J., Wirtz, V. J., Gómez‐Dantés, O., & Servan-Mori, E. E. (2020) · Diabetes Care · doi:10.2337/dc20-2192 · Cited by 25
Stochastic analysis of COVID-19 by a SEIR model with Lévy noise
Ding, Y., Fu, Y., & Kang, Y. (2021) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/5.0021108 · Cited by 25
Age-structured SIR model and resource growth dynamics: a COVID-19 study
Babajanyan, S. G., & Cheong, K. H. (2021) · Nonlinear Dynamics · doi:10.1007/s11071-021-06384-5 · Cited by 25
Dzúrová, D., & Květoň, V. (2021) · Applied Geography · doi:10.1016/j.apgeog.2021.102551 · Cited by 30
Ye, J. (2024) · JAMIA Open · doi:10.1093/jamiaopen/ooae047 · Cited by 25
Razzaq, O. A., Rehman, D. U., Khan, N. A., Ahmadian, A., & Феррара, М. (2020) · Results in Physics · doi:10.1016/j.rinp.2020.103715 · Cited by 24
Assessment of the Effects of Human Mobility Restrictions on COVID-19 Prevalence in the Global South
Abulibdeh, A. O., & Mansour, S. (2021) · The Professional Geographer · doi:10.1080/00330124.2021.1970592 · Cited by 25
The Drivers of Policies to Limit the Spread of COVID-19 in Europe
Bourdin, S., Miled, S. B., & Salhi, J. (2022) · Journal of risk and financial management · doi:10.3390/jrfm15020067 · Cited by 26
Govender, K., Nyamaruze, P., McKerrow, N., Meyer‐Weitz, A., & Cowden, R. G. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-007839 · Cited by 24
A novel approach for COVID-19 Infection forecasting based on multi-source deep transfer learning
Garg, S., Kumar, S., & Muhuri, P. K. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105915 · Cited by 25
Chen, Y.-T. (2022) · Health Policy and Technology · doi:10.1016/j.hlpt.2022.100699 · Cited by 28
Duarte, D. E., & Benetti, P. R. (2022) · Sociologias · doi:10.1590/18070337-120336 · Cited by 50
The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variantPreprint
Hogan, A. B., Wu, S. L., Doohan, P., Watson, O. J., Winskill, P., Charles, G. D., Barnsley, G., Riley, E. M., Khoury, D. S., Ferguson, N. M., et al. (2022) · medRxiv · doi:10.1101/2022.01.17.22269222 · Cited by 27
Self-citationMachine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study
Dabbah, M. A., Reed, A. B., Booth, A., Yassaee, A., Despotović, A., Klasmer, B., Binning, E., Aral, M., Plans, D., Morelli, D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95136-x · Cited by 28
Designing an optimal sequence of non‐pharmaceutical interventions for controlling COVID-19
Biswas, D., & Alfandari, L. (2022) · European Journal of Operational Research · doi:10.1016/j.ejor.2022.03.052 · Cited by 28
COVID ‐19 Policy Modeling in Sub‐Saharan Africa
Mueller, V., Sheriff, G. D., Keeler, C., & Jehn, M. (2020) · Applied Economic Perspectives and Policy · doi:10.1002/aepp.13078 · Cited by 25
The Spatiotemporal Interaction Effect of COVID-19 Transmission in the United States
Liu, L., Hu, T., Bao, S., Wu, H., Peng, Z., & Wang, R. (2021) · ISPRS International Journal of Geo-Information · doi:10.3390/ijgi10060387 · Cited by 27
COVID-19 preparedness—a survey among neonatal care providers in low- and middle-income countries
Klingenberg, C., Tembulkar, S. K., Lavizzari, A., Roehr, C. C., Ehret, D. E. Y., Vain, N. E., Mariani, G. L., Erdeve, Ö., Díaz, V. J. L., Velaphi, S., et al. (2021) · Journal of Perinatology · doi:10.1038/s41372-021-01019-4 · Cited by 25
Mashe, T., Takawira, F. T., Martins, L. D. O., Gudza-Mugabe, M., Chirenda, J., Munyanyi, M., Chaibva, B. V., Tarupiwa, A., Gumbo, H., Juru, A., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00434-4 · Cited by 25
Zhang, X. N., Owen, G. E., Green, M. A., Buchan, I. E., & Barr, B. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054101 · Cited by 25
SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020Preprint
Velumani, A., Nikam, C., Suraweera, W., Fu, S. H., Gelband, H., Brown, P., Bogoch, I. I., Nagelkerke, N. J. D., & Jha, P. (2021) · medRxiv · doi:10.1101/2021.03.19.21253429 · Cited by 23
Jassat, W., Cohen, C., Tempia, S., Masha, M., Goldstein, S., Kufa, T., Murangandi, P., Savulescu, D. M., Walaza, S., Bam, J., et al. (2020) · medRxiv · doi:10.1101/2020.12.21.20248409 · Cited by 25
Vacharathit, V., Srichatrapimuk, S., Manopwisedjaroen, S., Kirdlarp, S., Srisaowakarn, C., Setthaudom, C., Inrueangsri, N., Pisitkun, P., Kunakorn, M., Hongeng, S., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.021 · Cited by 22
Gutiérrez, E., Rubli, A., & Tavares, T. (2021) · Journal of Development Economics · doi:10.1016/j.jdeveco.2021.102774 · Cited by 27
Optimal non-pharmaceutical pandemic response strategies depend critically on time horizons and costs
Nowak, S. A., de Lima, P. N., & Vardavas, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-28936-y · Cited by 23
Viswanathan, M., Aly, H. F., Duncan, R. J., & Mandhan, N. (2021) · Journal of Consumer Affairs · doi:10.1111/joca.12351 · Cited by 26
Trentini, F., Guzzetta, G., Galli, M., Zardini, A., Manenti, F., Putoto, G., Marziano, V., Gamshie, W. N., Tsegaye, A., Greblo, A., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01967-w · Cited by 22
MULTIFRACTAL ANALYSIS OF COVID-19’S IMPACT ON CHINA’S STOCK MARKET
XU, N., Li, S., & Hui, X. (2021) · Fractals · doi:10.1142/s0218348x21502133 · Cited by 21
Broadbent, A., & Streicher, P. (2022) · Global Epidemiology · doi:10.1016/j.gloepi.2022.100074 · Cited by 22
The collateral fallout of COVID19 lockdown on patients with head injury from north-west India
Karthigeyan, M., Dhandapani, S., Salunke, P., Sahoo, S. K., Kataria, M. S., Singh, A., Gendle, C., Panchal, C., Chhabra, R., Jain, K., et al. (2021) · Acta Neurochirurgica · doi:10.1007/s00701-021-04723-4 · Cited by 20
Avaliação de tecnologias em saúde: tensões metodológicas durante a pandemia de Covid-19
Romero, C., Silva, J., Castro, R., Alves, M. R., & Franco, C. M. (2020) · Estudos Avançados · doi:10.1590/s0103-4014.2020.3499.006 · Cited by 108
Assessing Socioeconomic Vulnerabilities Related to COVID-19 Risk in India: A State-Level Analysis
Pathak, P. K., Singh, Y., Mahapatro, S. R., Tripathi, N., & Jee, J. (2020) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2020.348 · Cited by 23
Exploring equity in health and poverty impacts of control measures for SARS-CoV-2 in six countries
Sweeney, S., Capeding, T. P. J. Z., Eggo, R. M., Huda, M., Jit, M., Mudzengi, D. L., Naylor, N. R., Procter, S. R., Quaife, M., Serebryakova, L., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-005521 · Cited by 23
Djaafara, B. A., Whittaker, C., Watson, O. J., Verity, R., Brazeau, N. F., WİDYASTUTİ, W., Oktavia, D., Adrian, V., Salama, N., Bhatia, S., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02016-2 · Cited by 24
Self-citationWang, S., Tong, Y., Fan, Y., Liu, H., Wu, J., Wang, Z., & Fang, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-94060-4 · Cited by 20
Cai, R., Novosad, P. M., Tandel, V., Asher, S., & Malani, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050920 · Cited by 21
A framework for reconstructing SARS-CoV-2 transmission dynamics using excess mortality data
Ghafari, M., Watson, O. J., Karlinsky, A., Ferretti, L., & Katzourakis, A. (2022) · Nature Communications · doi:10.1038/s41467-022-30711-y · Cited by 22
Self-citationGómez–Restrepo, C., Sarmiento-Suárez, M. J., Alba-Saavedra, M., Calvo-Valderrama, M. G., Rincón, C., Ballesteros, L. M. G., Bird, V. J., Priebe, S., & van Loggerenberg, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-35789-y · Cited by 20
Park, J.-H., Lee, M. J., Tsai, M., Shih, H.-J., & Chang, J. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s439437 · Cited by 21
van Huizen, M., ter Horst, J. R. B. , Gruyter, H. L. M. D., Geurink, P. P., van Noort, G. J. V. D. H., Knaap, R. C. M., Nelemans, T., Ogando, N. S., Leijs, A. A., Urakova, N., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012100 · Cited by 21
Rizi, A. K., Faqeeh, A., Badie-Modiri, A., & Kivelä, M. (2022) · Physical review. E · doi:10.1103/physreve.105.044313 · Cited by 26
Clay, K., Abdelwahab, M., Bagwell, S., Barney, M., Burkle, E. M., Hawley, T., Rowden, T. K., LaVelle, M., Parker, A., & Rains, M. (2022) · Journal of Human Rights · doi:10.1080/14754835.2022.2082244 · Cited by 20
Adigun, O. T., Nzima, D. R., Maphalala, M. C., & Ndwandwe, N. D. (2022) · South African Journal of Higher Education · doi:10.20853/36-4-5178 · Cited by 23
The Psychological Mechanism of Internet Information Processing for Post-Treatment EvaluationPreprint
Vuong, Q., Le, T.-T., La, V., & Nguyen, M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4003161 · Cited by 20
Impact of COVID-19 Pandemic on Rheumatology Practice in Latin America
Fernández-Ávila, D. G., Correa, J. E. B., Romero-Alvernia, D., Kowalski, S. C., Sapag, A., Cachafeiro-Vilar, A., Meléndez, B., Santiago-Pastelín, C., Palleiro, D., Arrieta, D., et al. (2021) · The Journal of Rheumatology · doi:10.3899/jrheum.201623 · Cited by 19
Roquebert, B., Haïm‐Boukobza, S., Trombert‐Paolantoni, S., Lecorché, E., Verdurme, L., Foulongne, V., Burrel, S., Alizon, S., & Sofonea, M. T. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.076 · Cited by 22
Oral, T., & Günlü, A. (2021) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-020-00447-1 · Cited by 24
Individual’s daily behaviour and intergenerational mixing in different social contexts of Kenya
Fava, E. D., Adema, I. W., Kiti, M. C., Poletti, P., Merler, S., Nokes, D. J., Manfredi, P., & Melegaro, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-00799-1 · Cited by 19
Association of national and regional lockdowns with COVID-19 infection rates in Pune, India
Mave, V., Shaikh, A., Monteiro, J. M., Bogam, P., Pujari, B. S., & Gupte, N. (2022) · Scientific Reports · doi:10.1038/s41598-022-14674-0 · Cited by 19
Farrell, T., Gorrell, G., & Bontcheva, K. (2020) · Journal of Computational Social Science · doi:10.1007/s42001-020-00090-9 · Cited by 26
Modeling Complex Systems: A Case Study of Compartmental Models in Epidemiology
Siegenfeld, A. F., Kollepara, P. K., & Bar-Yam, Y. (2022) · Complexity · doi:10.1155/2022/3007864 · Cited by 22
Desafíos de la educación universitaria ante la virtualidad en tiempos de la pandemia
Díaz, L. C. S., García, S., Alvarado, G. D. P. P., & Verges, I. Y. (2021) · doi:10.31876/rcs.v27i.36992 · Cited by 18
The South African government’s COVID-19 response: protecting lives and livelihoods
Blecher, M., Davén, J., Meyer‐Rath, G., Silal, S. P., Makrelov, K., & van Niekerk, M. (2022) · South African Health Review · doi:10.61473/001c.70437 · Cited by 19
Waghmare, A., Krantz, E. M., Baral, S., Vasquez, E., Loeffelholz, T., Chung, L., Pandey, U., Kuypers, J. M., Duke, E. R., Jerome, K. R., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa451 · Cited by 18
Early estimates of COVID-19 infections in small, medium and large population clusters
Siraj, A. S., Worku, A., Berhane, K. T., Aregawi, M. W., Eshetu, M. K., Mirkuzie, A. H., Berhane, Y., & Siraj, D. S. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003055 · Cited by 20
Mayorga, L., Samartino, C. G., Flores, G., Masuelli, S., Sánchez, M. V., Mayorga, L. S., & Sánchez, C. G. (2020) · BMC Public Health · doi:10.1186/s12889-020-09843-7 · Cited by 18
Using telehealth to support community health workers in Uganda during COVID-19: a mixed-method study
Kok, M. O., Terra, T., Tweheyo, R., van der Hoeven, M., Ponce, M. C., van Furth, A. M., & Rutebemberwa, E. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09217-w · Cited by 20
Metadata
- Authors
- Walker, P. G. T., Whittaker, C., Watson, O. J., Baguelin, M., Winskill, P., Hamlet, A., Djafaara, B. A., Cucunubá, Z., Olivera Mesa, D., Green, W., Thompson, H., Nayagam, S., Ainslie, K. E. C., Bhatia, S., Bhatt, S., Boonyasiri, A., Boyd, O., Brazeau, N. F., Cattarino, L., Cuomo-Dannenburg, G., Dighe, A., Donnelly, C. A., Dorigatti, I., van Elsland, S. L., FitzJohn, R., Fu, H., Gaythorpe, K. A. M., Geidelberg, L., Grassly, N., Haw, D., Hayes, S., Hinsley, W., Imai, N., Jorgensen, D., Knock, E., Laydon, D., Mishra, S., Nedjati-Gilani, G., Okell, L. C., Unwin, H. J., Verity, R., Vollmer, M., Walters, C. E., Wang, H., Wang, Y., Xi, X., Lalloo, D. G., Ferguson, N. M., & Ghani, A. C.
- Affiliations
- Imperial College London (GB)
- Brown University (US)
- London School of Hygiene & Tropical Medicine (GB)
- MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
- University of Oxford (GB)
- Liverpool School of Tropical Medicine (GB)
- Corresponding author
- Walker, Patrick G. T.
- Whittaker, Charles
- Watson, Oliver J.
- Ferguson, Neil M.
- Ghani, Azra C.
- ORCID
- Walker, Patrick G. T.
- Whittaker, Charles
- Watson, Oliver J.
- Baguelin, Marc
- Winskill, Peter
- Hamlet, Arran
- Djafaara, Bimandra A.
- Cucunubá, Zulma
- Olivera Mesa, Daniela
- Green, Will
- Thompson, Hayley
- Nayagam, Shevanthi
- Ainslie, Kylie E. C.
- Bhatia, Sangeeta
- Bhatt, Samir
- Boonyasiri, Adhiratha
- Boyd, Olivia
- Brazeau, Nicholas F.
- Cattarino, Lorenzo
- Cuomo-Dannenburg, Gina
- Dighe, Amy
- Donnelly, Christl A.
- Dorigatti, Ilaria
- FitzJohn, Rich
- Fu, Han
- Gaythorpe, Katy A. M.
- Geidelberg, Lily
- Grassly, Nicholas
- Haw, David
- Hayes, Sarah
- Hinsley, Wes
- Imai, Natsuko
- Jorgensen, David
- Knock, Edward
- Laydon, Daniel
- Mishra, Swapnil
- Nedjati-Gilani, Gemma
- Okell, Lucy C.
- Unwin, H. Juliette
- Verity, Robert
- Vollmer, Michaela
- Walters, Caroline E.
- Wang, Haowei
- Wang, Yuanrong
- Xi, Xiaoyue
- Lalloo, David G.
- Ferguson, Neil M.
- Ghani, Azra C.
- Venue
- Science
- Published
- 2020-07-24
- Volume
- 369
- Issue
- 6502
- Pages
- 413-422
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7292504
- OpenAlex
- W3035706118
- Semantic Scholar
- 4f2e1c57a649d91d0b3322bc76c3ae8cdebc08a3
- Cited by
- 993
- References
- 54
- Citations by year
- 2026: 18 · 2025: 42 · 2024: 69 · 2023: 122 · 2022: 215 · 2021: 281 · 2020: 245
- FWCI
- 34.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Wellcome (221350/Z/20/Z)
- Medical Research Council
- National Institute for Health Research
- Community Jameel
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Social Sciences › Sociology and Political Science › COVID-19 Prevention and Impact
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 pandemic, low- and middle-income countries, mitigation measures, suppression strategy, health system capacity, excess mortality, intergenerational interaction, disease severity, contact patterns, age structure, quality of care, pandemic response
- MeSH terms
- COVID-19, Developing Countries, Humans, Patient Acceptance of Health Care, Pneumonia, Viral, Poverty, Public Health, Global Health, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.